Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000946075 | SCV001092168 | benign | Qualitative or quantitative defects of dysferlin | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001563743 | SCV001786751 | likely benign | Miyoshi muscular dystrophy 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271780 | SCV001786833 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001563801 | SCV001786834 | likely benign | Distal myopathy with anterior tibial onset | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003913205 | SCV004731008 | likely benign | DYSF-related disorder | 2019-05-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001271780 | SCV001453220 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-01-24 | no assertion criteria provided | clinical testing |